Leveraging Prior Healthy Participant Pharmacokinetic Data to Evaluate the Impact of Renal and Hepatic Impairment on Ritlecitinib Pharmacokinetics.
Journal Information
Full Title: AAPS J
Abbreviation: AAPS J
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Conflict of InterestThe authors are employees of Pfizer Inc. and may own shares/stock options in Pfizer Inc. Conflict of Interest The authors are employees of Pfizer Inc. and may own shares/stock options in Pfizer Inc."
Funding Disclosure
Evidence found in paper:
"Funding This study was funded by Pfizer Inc. Medical writing support was provided by Katy Beck, PhD, of Engage Scientific Solutions and funded by Pfizer Inc."
Protocol Registration
Evidence found in paper:
"Trial Registration ClinicalTrials.gov NCT04037865, NCT04016077, NCT02309827, NCT02684760, and NCT02969044."
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025